Project to develop a blood-based test to identify patients with early pancreatic cancer receives PanKind funding boost.

The test is based on a critical WEHI discovery of proteins that can identify early pancreatic cancer in patients. Currently, there are no early-detection biomarkers for the disease.

Researchers hope the test could, in the future, be used by general practitioners and oncologists as a tool for early intervention to enable more effective treatment options for patients.